Skip to Content
Home > Services > Cancer Care > Successful Outcomes > Clinical Trials > Clinical Trials Search Results
A randomized, Placebo Controlled Phase II trial of Afatinib (BIBW2992) as Adjuvant Therapy following Chemoradiation in patients with Head and Neck squamous cell carcinoma at High risk of recurrence
Send Us Your Questions, Comments or Feedback.
Awards & Certifications
Follow Us Online
©2014 Cone Health ~ Greensboro, NC